Delivery Order SPE2DB22D1106-SPE2DB25FEYN7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Kineret (anakinra) 100 mg/0.67 mL syringes totaling $3,580.88 on July 31, 2025, with an ultimate completion date of August 21, 2025. This non-set-aside, firm fixed-price delivery order represents a pediatric or adult rheumatoid arthritis therapeutic supply under a competitive procurement process. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a ceiling value of $11,637.86 and firm fixed pricing. This delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $3,967.70 delivery order to Amerisourcebergen Drug Corporation for Kineret 100 mg/0.67 ml syringes. The firm fixed price order is for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania, and has a period of performance from August 24, 2023 through September 15, 2023. As a major supplier of medical materiel to the U.S. Department of Defense, the Defense Logistics Agency utilizes contracts such as Amerisourcebergen's...
- The Defense Logistics Agency awarded a $4,761 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.67 ml syringes of Kineret. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products to various Department of Defense components. Amerisourcebergen will deliver the Kineret syringes from its facility in Conshohocken, Pennsylvania by August 30th to fulfill this requirement placed by the Defense Logistics Agency....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it...
- Amerisourcebergen Drug Corporation, operating from its Conshohocken, Pennsylvania corporate office, has been awarded a $7,141.86 firm fixed price delivery order contract from the Defense Logistics Agency Troop Support Medical to provide 4562493042 Kineret 100 mg/0.67 ml syringes. The contract has no set-aside designation and requires delivery of the specified pharmaceutical by November 6, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $92,315 contract is for the supply of the biologic drug Kineret (anakinra) 100mg prefilled syringes. The award is not designated as a set-aside contract. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, valued at $1,614.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the delivery of 4,564,159,150 units of the specialty pharmaceutical drug Kineret 100 mg/0.67 ml syringe. The contract has a firm fixed price and is a delivery order with an ultimate completion date of April 24, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYN7Delivery Order
The Defense Logistics Agency awarded a $30,970.59 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Kineret 100 mg/0.67 ml syringes. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used primarily for treating rheumatoid arthritis and other inflammatory conditions, making this procurement consistent with the Defense Health Agency's pharmaceutical supply requirements for military personnel and beneficiaries. This delivery order represents a child contract action under AmerisourceBergen's larger $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen's extensive portfolio of federal medical supply contracts demonstrates its established capability as a critical pharmaceutical distributor for military healthcare systems. The company's competitive award history and scale of operations position it as a primary vendor within the Defense Logistics Agency's pharmaceutical supply chain supporting worldwide military medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.0k | 7/18/25 |